Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Initial Review, 34045-34046 [2012-13908]

Download as PDF Federal Register / Vol. 77, No. 111 / Friday, June 8, 2012 / Notices Dated: June 1, 2012. James Scanlon, Deputy Assistant Secretary for Planning and Evaluation, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2012–13987 Filed 6–7–12; 8:45 am] BILLING CODE 4151–05–P Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427– 1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 31, 2012. Carolyn M. Clancy, Director. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2012–13773 Filed 6–7–12; 8:45 am] BILLING CODE 4160–90–M Agency for Healthcare Research and Quality mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘Patient-Centered Outcomes Research—Dissemination by Health Professionals Associations (PCOR–DHPA) (R18)’’ applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Patient-Centered Outcomes Research—Dissemination by Health Professionals Associations (PCOR–DHPA) (R18). Dates: June 20, 2012 (Open on June 20 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting). Place: Crowne Plaza Rockville, 3 Research Court, Rockville, MD 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and 16:23 Jun 07, 2012 Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427– 1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 31, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–13771 Filed 6–7–12; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Meeting VerDate Mar<15>2010 34045 Jkt 226001 BILLING CODE 4160–90–M Agency for Healthcare Research and Quality DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Meeting Centers for Disease Control and Prevention In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the ‘‘Building the Science of Public Reporting (R21)’’ applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Building the Science of Public Reporting (R21). Date: June 20–21, 2012 (Open on June 20 from 8 a.m. to 8:15 a.m. and closed for the remainder of the meeting). Place: Crowne Plaza Rockville, 3 Research Court, Rockville, MD 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non-confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Initial Review The meeting announced below concerns Cooperative Research Agreements Related to the World Trade Center Health Program (U01), PAR 12– 126, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 8 a.m.–5 p.m., July 17, 2012 (Closed). 8 a.m.–5 p.m., July 18, 2012 (Closed). Place: Residence Inn Alexandria Old Town, 1456 Duke Street, Alexandria, Virginia 22314, Telephone (703) 548–5474. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Cooperative Research Agreements Related to the World Trade Center Health Program (U01) PAR 12–126’’. Contact Person for More Information: Joan Karr, Ph.D., Scientific Review Officer, CDC/ NIOSH, 1600 Clifton Road, Mailstop E–74, Atlanta, Georgia 30333, Telephone: (404) 498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\08JNN1.SGM 08JNN1 34046 Federal Register / Vol. 77, No. 111 / Friday, June 8, 2012 / Notices Dated: May 31, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: June 4, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–13908 Filed 6–7–12; 8:45 am] [FR Doc. 2012–13922 Filed 6–7–12; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Ethics Subcommittee (ES) mstockstill on DSK4VPTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned subcommittee: Time and Date: 9:30 a.m.–12:30 p.m. EDT, Friday, June 29, 2012. Place: Teleconference. Status: Open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period. A public comment period is tentatively scheduled for 12 p.m.–12:15 p.m. To participate in the teleconference, please dial (877) 928–1204 and enter code 4305992. Purpose: The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. Matters To Be Discussed: Agenda items will include the following: Addition of ethics standards to the accreditation process for public health departments; ethical considerations relating to use of travel restrictions for the control of communicable diseases and possible revisions to CDC’s standard operating procedures; progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges; approaches for evaluating the impact of public health ethics; and strategies for increasing collaboration between public health ethics and public health law. The agenda is subject to change as priorities dictate. Contact Person for More Information: Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC–ES, 1600 Clifton Road NE., M/S D–50, Atlanta, Georgia 30333. Telephone: (404) 639–4690. Email: dbarrett@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 16:23 Jun 07, 2012 Jkt 226001 [Document Identifier CMS–10434] Agency Information Collection Activities: Proposed Collection; Comment Request; Webinars Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Type of Information Collection Request: New collection (request for a new OMB control number). Title of Information Collection: Medicaid and CHIP Program (MACPro). Use: Medicaid, authorized by Title XIX of the Social Security Act and, CHIP, reauthorized by the Children’s Health Insurance Program Reauthorization Act of 2009 (CHIPRA), play an important role in financing health care for approximately 48 million people throughout the country. By 2014, it is expected that an additional 16 million people will become eligible for Medicaid and CHIP as a result of the Affordable Care Act (Pub. L. 111–148). In order to implement the statute, CMS must provide a mechanism to ensure timely approval of Medicaid and CHIP State plans, waivers and demonstrations and provide a repository for all Medicaid and CHIP program data that supplies data to populate AGENCY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Healthcare.gov and other required reports. Additionally, 42 CFR 430.12 sets forth the authority for the submittal and collection of State plans and plan amendment information. Pursuant to this requirement, CMS has created the MACPro system. Generally, MACPro will be used by both State and CMS officials to: Improve the State application and Federal review processes, improve Federal program management of Medicaid programs and CHIP, and standardize Medicaid program data. More specifically, it will be used by State agencies to (among other things): (1) Submit and amend Medicaid State Plans, CHIP State Plans, and Information System Advanced Planning Documents, and (2) submit applications and amendments for State waivers, demonstration, and benchmark and grant programs. It will be used by CMS to (among other things): (1) Provide for the review and disposition of applications, and (2) monitor and track application activity. This system will be operational in phases, beginning with this first phase or Phase 1, MACPro will include the following three authorities: State Plan and CHIP Eligibility, Alternative Benchmark plans, and 1115 Waiver Demonstration portions/modules to be implemented before January 1, 2013. A paper-based version of the MACPro instrument would be sizable and time consuming for interested parties to follow as a paper-based instrument. In our effort to provide the public with the most efficient means to make sense of the MACPro system, we will be conducting four webinars in lieu of including a paper-based version of MACPro on CMS’ PRA-related Web site. The webinars will be held: 1. June 13, 2012, from 1 to 3 p.m. EST. 2. June 20, 2012, from 1 to 3 p.m. EST. 3. June 27, 2012, from 1 to 3 p.m. EST. 4. July 11, 2012, from 1 to 3 p.m. EST. Please note that the webinars will be recorded by CMS and can be accessed by the public at https:// www.medicaid.gov/State-ResourceCenter/Events-and-Announcements/ Events-and-Announcements.html at any time during the duration of the public comment period. Each webinar will present the most current MACPro information so they are not expected to be identical. No login or password is needed. Form Number: CMS–10434 (OCN 0938–New). Frequency: Annual and once. Affected Public: State, Local, or Tribal Governments. Number of Respondents: 56. Total Annual Responses: 15. Total Annual Hours: 15,736 (or 5,245 hr for each of the three authorities). (For policy questions E:\FR\FM\08JNN1.SGM 08JNN1

Agencies

[Federal Register Volume 77, Number 111 (Friday, June 8, 2012)]
[Notices]
[Pages 34045-34046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13908]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Initial Review

    The meeting announced below concerns Cooperative Research 
Agreements Related to the World Trade Center Health Program (U01), PAR 
12-126, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Times and Dates:
8 a.m.-5 p.m., July 17, 2012 (Closed).
8 a.m.-5 p.m., July 18, 2012 (Closed).
    Place: Residence Inn Alexandria Old Town, 1456 Duke Street, 
Alexandria, Virginia 22314, Telephone (703) 548-5474.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Cooperative Research Agreements Related to the World 
Trade Center Health Program (U01) PAR 12-126''.
    Contact Person for More Information: Joan Karr, Ph.D., 
Scientific Review Officer, CDC/NIOSH, 1600 Clifton Road, Mailstop E-
74, Atlanta, Georgia 30333, Telephone: (404) 498-2506.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


[[Page 34046]]


    Dated: May 31, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-13908 Filed 6-7-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.